Medicine Name: Intalfa 3MIU Injection Form: Injectable solution (prefilled syringe or vial) Strength: Interferon Alpha‑2B 3 MIU per 1 ml dose Manufacturer: Intas Pharmaceuticals Ltd Composition : Active Ingredient: • Interferon Alpha‑2B — 3 MIU (recombinant human interferon) Therapeutic Class : Class: Antineoplastics / Immunomodulators — cytokine therapy Action: Mimics the body’s natural interferon‑alpha to modulate the immune system, interfere with viral replication, and inhibit tumor cell growth Intalfa 3 MIU contains interferon alpha‑2b, a recombinant human cytokine that helps modulate the immune system and inhibit viral replication or tumor growth. Common Uses : Chronic Hepatitis B & C infections: Helps the body fight viral infection and reduce liver inflammation. Certain cancers: Used as part of therapy for leukemia, melanoma, lymphoma, and other malignancies to slow tumor growth. Viral warts / papillomavirus infections: Can be used for resistant warts. Immunomodulatory therapy: Enhances the body’s natural antiviral and anticancer immune response. Intalfa 3 MIU Injection (Interferon alfa-2b) is a prescription medicine used to treat chronic hepatitis B and C, as well as cancers like hairy cell leukemia, follicular lymphoma, and melanoma. It boosts the immune system to fight viral infections and inhibit cancer cell growth. It is administered by a professional, often requiring cold-chain storage. How it works : Mimics natural interferon-alpha in the body. Activates immune cells, increases antiviral proteins, and slows viral replication. In cancer therapy, it inhibits tumor cell proliferation and enhances immune-mediated tumor destruction.